| Literature DB >> 26623019 |
Yusuke Kimura1, Masashi Ishikawa1, Yoko Hori1, Tadashi Okabe2, Atsuhiro Sakamoto1.
Abstract
Previous reports have shown that electroconvulsive therapy (ECT) is efficacious in the treatment of neuropathic pain; however, its mechanism of action remains unclear. The present study aimed to understand these mechanisms by investigating the alterations in the expression of neuropeptide Y (NPY) and interleukin-1β (IL-1β) in the prefrontal cortex. A rat model of neuropathic pain produced by chronic constrictive injury of the sciatic nerve was used, and mechanical and thermal hyperalgesia were evaluated starting 2 days after the injury. Using a pulse generator, ECT was administered to the rodents for 6 days from days 7-12 after the injury. Thermal and mechanical stimulation were administered to assess pain thresholds. Quantitative polymerase chain reaction, used to measure gene expression levels in the prefrontal cortex, showed that NPY and IL-1β gene expression levels in the prefrontal cortex increased following the injury. The present results indicate that these gene expression level variations may be associated with the mechanisms underlying the effect of ECT in treating neuropathic pain.Entities:
Keywords: electroconvulsive stimulation; interleukin-1β; messenger RNA; neuropeptide Y; prefrontal cortex
Year: 2015 PMID: 26623019 PMCID: PMC4660606 DOI: 10.3892/br.2015.525
Source DB: PubMed Journal: Biomed Rep ISSN: 2049-9434